Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory is a research paper published in EBioMedicine (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: HHSN261201500003I
Innovative Medicines Initiative
Grant: 115854
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854
Innovative Medicines Initiative
Grant: 115861
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861
Medical Research Council
Grant: MR/K019708/1
NCI NIH HHS
Grant: HHSN261201500003C
FIC NIH HHS
Grant: D43 TW011818
Medical Research Council
Grant: MC_UU_00033/2
London School of Hygiene and Tropical Medicine
National Institutes of Health
Horizon 2020 Framework Programme
Janssen Pharmaceuticals
Ministry of Higher Education, Research and Innovation
European Commission
Frederick National Laboratory for Cancer Research
Innovative Medicines Initiative
Horizon 2020
Merck Sharp and Dohme
European Federation of Pharmaceutical Industries and Associations
Institut National de la Santé et de la Recherche Médicale
FWCI
1.67
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals